ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
April 19, 2021 Cover
Volume 99, Issue 14
A few ambitious companies are pioneering a new industry serving the emerging sector
Cover image:New laboratory space at Aldevron. The manufacturer of starting materials for cell and gene therapies and enzymes plans to more than triple capacity this year.
Credit: Aldevron
A few ambitious companies are pioneering a new industry serving the emerging sector
Biotech firms hope less harsh, more effective conditioning therapies will expand the kinds of diseases treated by stem cell transplants
Industry is pushing back against California’s use of this rationale to regulate these chemicals as a class
Bias and lack of diversity in textbook images can harm students
Use these casual conversations to guide your career exploration and grow your network
Chemical educator and Compound Interest blogger Andy Brunning provides a taste of how chemists identify and make artificial flavors.
CDC’s vaccine advisory committee will watch and wait before deciding on the J&J vaccine